AstraZeneca PLC
AZNPharmaceuticals
£130.52+2.26%As of Oct 29vs prior close
- Market cap
- $269.6B
- P/E (TTM)
- 25.8×
- P/E (FY1)
- 17.1×
- From 52W high
- 0.00%
- EPS (TTM)
- –
- Revenue (LTM)
- $61.4B
- Net margin
- 17.02%
Nomior Score
52
Steady ProfileTop 47% of the scored universe
Growth51
Quality61
Value37
Momentum—
Resilience59
Growth
+9.82%revenue a year over 3 fiscal years
YE22 $44.4BLTM $61.4B
Connections
Revenue to profitYE25
17% of revenue became net profit, up 4 pts on a year.